USNA — USANA Health Sciences Share News
0.000.00%
Last trade - 00:00- $284.17m
- $160.28m
- $925.26m
Brief: Usana Health Sciences - Enters First Amendment To Credit Agreement On Sept 30, 2026 - SEC Filing
USANA Health Sciences Q2 sales fall amid weaker Hiya and Rise performance
Brief: USANA Health Sciences Q2 EPS USD -1.16
Usana Health Sciences Inc Expected To Post Earnings Of 43 Cents A Share: Earnings Preview
Brief: USANA Health Sciences Renews Four-Year Partnership With Nordiq Canada, Deepening Commitment To Clean Sport And Elite Athlete Nutrition
Brief: Usana's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare Products
USANA Health Sciences Q1 revenue flat, profit drops
Brief: USANA Health Sciences Q1 EPS USD 0.41
USANA Health Sciences reports Q4 net sales rise
Corrected: BRIEF-USANA Health Sciences Q4 EPS USD -0.1
Brief: Kevin Guest Returns To Usana Health Sciences As CEO
Brief: Usana Extends Partnership With World-Famous Jamaican Bobsled Team To Help Fuel Their Olympic Dreams
Brief: USANA Health Sciences Outlook FY EPS USD 0.78
Brief: USANA Health Sciences Provides Preliminary Third Quarter Results
Nutritional products maker USANA's prelim Q3 sales miss estimates
Brief: USANA Launches Next-Generation Celavive Skincare Advanced Formulas, Expert Ambassadors, Proven Results
USANA Q2 adjusted profit beats estimate
Usana Health Sciences Inc Expected To Post Earnings Of 54 Cents A Share: Earnings Preview
Brief: Usana Health Sciences Enters Third Amended & Restated Credit Agreement With Bank of America